Invent Medic prepare for market launch of TVS
Invent medic Sweden AB ("invent medic"), as previously reported, has been granted a marketing authorization, CE marking, on its first product, TVS. Invent Medic has during the late winter and spring prepared for market launch by participating in relevant conferences and events, having initial contacts with pharmacies and through the recruitment of a Supply Chain Manager who will be responsible for the product flow within the company.
In early July 2018, Invent Medic received the right to CE mark the TVS and market launch is scheduled to take place after the summer of 2018. In spring and summer 2018, invent Medic has conducted a large number of preparatory activities for the planned market launch. For example, the company has participated in conferences and events. The company has, among other things, been presenting Arcamea, the company’s women's health brand at the Urotherapists Annual Congress and the OGU days, which is a training conference for Obstetrics and Gynecologists. The responses have been positive, and the profession shows high interest in the product and the brand Arcamea. Participation at conferences gives the company a good network opportunity and a good opportunity to present the vision for the brand. In addition, the company has had initial contacts with pharmacies prior to the market launch in order to pre-establish interest for the TVS.
In June 2018 the company employed Helene Dahlberg as Supply Chain Manager. Dahlberg is an engineer by trade with extensive experience in procurement, purchasing and logistics, among other things. Dahlberg will manage the product flow, implying that Dahlberg has a key position in the market launch activities of TVS. Invent Medic also has continued major collaborations with highly skilled consults to ensure digital marketing and a future launch on the international market.
For more information please contact
Karin Bryder, CEO
Phone: +46 (0)723811710
E-mail: info@inventmedic.com
Invent Medic Sweden AB, Company registration number 556682-1046, has developed a medical device for non-surgical relief of female stress urinary incontinence. The inventors behind the product, Jan Clarén and Lars-Olof Henriksson, have been involved in the development and performance of the surgical method TVT, which is now known as the Golden Standard for surgical treatment of female stress incontinence. The product is based on the same scientific basis and has similar mechanism of action as the surgical method but is based on a non-surgical support and is designed so that the woman can use the product when needed. This product has the potential to satisfy a major medical need and could thus have a significant market value. Invent medic's vision is to offer new and innovative medical devices and treatment methods to women with the goal of improving their health and quality of life. The offer shall include safe, effective and safe products and treatment methods that should be easy to use and which will provide health economic benefits to society. Invent Medic Sweden AB is listed on Aktietorget. Ticker is IMS and the share's ISIN code is SE0007603402. For more information see www.inventmedic.com and www.spotlightstockmarket.com.